Sanofi SA (ADR)  

(Public, NYSE:SNY)   Watch this stock  
Find more results forSNY
49.84
-2.04 (-3.93%)
After Hours: 50.00 +0.16 (0.32%)
Jun 29, 7:35p.m. GMT-4  
NYSE real-time data - Disclaimer
Currency in USD
Range 49.70 - 50.61
52 week 43.57 - 57.42
Open 50.18
Vol / Avg. 0.00/1.98M
Mkt cap 137,190.50M
P/E 27.27
Div/yield 1.61/3.23
EPS 1.83
Shares 1,309.91M
Beta 0.93
Inst. own 20%

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 12.22% 13.37%
Operating margin 15.78% 18.01%
EBITD margin - 30.25%
Return on average assets - 4.71%
Return on average equity - 7.77%
Employees 113,496 -
CDP Score - 97 B

Address

54 rue la Boetie, Paris 8
PARIS, 75008
France
+33-1-53774000 (Phone)
+33-1-53774463 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Sanofi is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products. The emerging markets platform includes products from all three of the Company's principal activities. Under the Company's Pharmaceuticals business, products are grouped into the key fields of diabetes solutions, rare diseases, multiple sclerosis, oncology, thrombosis and cardiovascular disease prevention, nephrology and bio-surgery. The Human Vaccines activity is operated through Sanofi Pasteur. The Animal Health activity is carried out through Merial.

Officers and directors

Serge Weinberg Chairman of the Board
Age: 63
Bio & Compensation  - Reuters
Olivier Brandicourt Chief Executive Officer
Bio & Compensation  - Reuters
Jerome Contamine Executive Vice President - Chief Financial Officer, Member of the Executive Committee and Global Leadership Team
Age: 57
Bio & Compensation  - Reuters
Peter Guenter Executive Vice President - Global Commercial Operations, Member of the Executive Committee and the Global Leadership Team
Bio & Compensation  - Reuters
David P. Meeker M.D. Member of the Executive Board and Executive Vice President - Genzyme and Member of the Global Leadership Team
Bio & Compensation  - Reuters
Pascale Witz Executive Vice President - Global Divisions & Strategic Commercial Development, Member of the Executive Committee and the Global Leadership Team
Bio & Compensation  - Reuters
Carsten Hellmann Executive Vice President - Animal Health and Member of the Global Leadership Team
Age: 49
Bio & Compensation  - Reuters
Karen Marie Linehan Member of the Executive Board, Member of the Management Board, Senior Vice President, General Counsel
Age: 56
Bio & Compensation  - Reuters
Roberto Pucci Senior Vice President - Human Resources, Member of the Executive Committee and the Global Leadership Team
Age: 50
Bio & Compensation  - Reuters
Olivier Charmeil Senior Vice President - Vaccines, Member of the Executive Committee and Global Leadership Team
Age: 51
Bio & Compensation  - Reuters